Salicylamide

Salicylamide (CAS 65-45-2) is a pharmaceutical-grade compound manufactured directly by Polpharma in monoclinic crystalline form (space group I2/a), currently in commercial status and complying with USP standards. Note that in patent-protected markets such as Poland, the supplier states this product is developed only for regulatory-submission or R&D purposes, not general sale; it is offered across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.